BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31413068)

  • 1. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
    Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
    Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
    Morkel M; Ellmann A; Warwick J; Simonds H
    Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
    Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
    J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining Characteristics of Nodal Disease on PET/CT Scans in Patients With HIV-Positive and -Negative Locally Advanced Cervical Cancer in South Africa.
    Minnaar CA; Baeyens A; Ayeni OA; Kotzen JA; Vangu MD
    Tomography; 2019 Dec; 5(4):339-345. PubMed ID: 31893232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
    Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added value of para-aortic surgical staging compared to
    De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
    Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
    Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
    Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
    Rose PG; Adler LP; Rodriguez M; Faulhaber PF; Abdul-Karim FW; Miraldi F
    J Clin Oncol; 1999 Jan; 17(1):41-5. PubMed ID: 10458216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.
    Lin WC; Hung YC; Yeh LS; Kao CH; Yen RF; Shen YY
    Gynecol Oncol; 2003 Apr; 89(1):73-6. PubMed ID: 12694656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of ¹⁸F-FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma.
    Akkas BE; Demirel BB; Vural GU
    Nucl Med Commun; 2012 Oct; 33(10):1081-8. PubMed ID: 22926065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.
    Goyal BK; Singh H; Kapur K; Duggal BS; Jacob MJ
    Int J Gynecol Cancer; 2010 Aug; 20(6):1041-5. PubMed ID: 20683414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
    Akkas BE; Demirel BB; Dizman A; Vural GU
    Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma.
    Fleming S; Cooper RA; Swift SE; Thygesen HH; Chowdhury FU; Scarsbrook AF; Patel CN
    Clin Radiol; 2014 Dec; 69(12):1235-43. PubMed ID: 25439186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
    Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.